The use of radioactive Iodine plays an important role in the treatment of some diseases and diagnosis of others, since they have suitable half-life. The radioactivity emitted from the dissolution of radioactive I-123 and I-125, such as the emission of Auger electrons, positrons and gamma rays reduce the spread of these diseases. Therefore, in this work we discuss the Iodine production via indirect reactions. In order to calculate the cross sections of these reactions for the mentioned target elements, we recommended the cross sections for EXFOR library using the recom.m program, which is written in the present work using Matlab-8, the data are taken from different authors. In order to supply accurate databases for different practical purposes such as proton beam energy monitoring, I-123 and I-125 radioisotopes production, we have evaluated the cross section collected from IAEA for EXFOR library measured by different authors of (p,xn), (d,xn) nuclear process. The selected data and our recommended cross sections were developed for practical applications. Since the preliminary overview of the cross section measurements up to 160MeV showed that there are discrepancies between the literature results.

Periodical:

International Letters of Chemistry, Physics and Astronomy (Volume 63)

Pages:

90-97

Citation:

I. T. Al-Alawy and R. S. Mohammed, "Nuclear Data Relevant to the Production of Radioiodine I-123, I-125 by Indirect Route and Medical Applications", International Letters of Chemistry, Physics and Astronomy, Vol. 63, pp. 90-97, 2016

Online since:

Jan 2016

Authors:

Keywords:

Distribution:

Open Access

This work is licensed under a

Creative Commons Attribution 4.0 International License

References:

[1] D. C. Washington, Availability of Radioactive Isotopes: Announcement from Headquarters, Manhattan Project, Journal of Science and Technology, 103(2685), 71 (1946).

DOI: 10.1126/science.103.2685.697[2] (IAEA) International Atomic Energy Agency, Charged particle cross-section database for medical radioisotope production: diagnostic radioisotopes and monitor reactions, No. 1011–4289, Vienna, 4, (2001).

[3] V. R. Narra, R. W. Howell, R. S. Harapanhalli, K. S. Sastry and D. V. Rao, Radiotoxicity of some Iodine-123, Iodine-125, and Iodine- 131-labeled compounds in mouse testes: Implications for radiopharmaceutical design, Journal of Nuclear Medicine, 33(12), 2196 (1992).

[4] E. Rault, Comparison of Image Quality of Different Iodine Isotopes (I-123, I-124 and I-131), Journal of Cancer Biotherapy and Radiopharmaceuticals, 22(3), 423–430 (2007).

DOI: 10.1089/cbr.2006.323[5] R. M. Lambrecht and A. P. Wolf, 'Cyclotron and Short-Lived Halogen Isotopes for Radiopharmaceutical Applications. In New Developments in Radiopharmaceuticals and Labelled Compounds, (IAEA) Vienna, 1, 275-290 (1973).

[6] H. Ragde and L. Korb, Brachytherapy for Clinically Localized Prostate Cancer, Journal of Seminars in Surgical Oncology, 18, 45-51 (2000).

DOI: 10.1002/(sici)1098-2388(200001/02)18:1<45::aid-ssu7>3.3.co;2-t[7] N. V. Kurenkov, A. B. Malinin, A. A. Sebyakin and N. I. Venikov, Excitation functions of proton-induced nuclear reactions on Xe-124. production of I-123, Journal of Radioanalytical and Nuclear Chemistry, Letters, 135, 39 (1989). .

DOI: 10.1007/bf02165458[8] F. Tarkanyi, S. M. Qaim, G. Stocklin, M. Sajjad, R. M. Lambrect and H. Schweickert, Excitation function of (p, 2n) and (p, pn) reactions and differential integral yield of I-123 in proton induced nuclear reactions on highly enriched Xe-124, Journal of Applied Radiation and Isotopes, 42, 221 (1991).

DOI: 10.1016/0883-2889(91)90080-k[9] a, b, c] S. Takacs, F. Tarkanyi and A. Hermanne, Validation and upgrade of the recommended cross section data of charged particle reactions to produce gamma emitter radioisotopes, Journal of Nuclear Institutes and Methods in Physics Research, Sect. B., 240, 790 (2005).

DOI: 10.1016/j.nimb.2005.06.209[10] a, b] A. Hermanne, F. Tarkanyi, S. Takacs, R. AdamRebeles, A. Ignatyuk, S. Spellerberg and R. Schweikert, Limitation of the 1ong-lived Te-121 contaminant in production of I-123 through the 124Xe(p, x) route, Journal of Applied Radiation and Isotopes, 69, 358 (2011).

DOI: 10.1016/j.apradiso.2010.10.013[11] S. R. Wilkins, S. T. Shimose, H. H. Hines, J. A. Jungerman, F. Hegedus and G. L. Denardo, Excitation functions and yields for I-123 production using the 127I(p, 5n)123-Xe reaction, Journal of Applied Radiation and Isotopes, 26, 279 (1975).

DOI: 10.1016/0020-708x(75)90162-3[12] a, b] A. M. J. Paans, W. Vaalburg, G. VanHerk and M. G. Woldring, Excitation function for the production of I-123 via the 127-I (p, 5n)123-Xe reaction, Journal of Applied Radiation and Isotopes, 27, 465 (1976).

DOI: 10.1016/0020-708x(76)90068-5[13] a, b] M. Diksic and L. Yaffe, A study of I-127(p, xn) and I-127(p, pxn) reactions with special emphasis on production of Xe-123, Journal of Inorganic and Nuclear Chemistry, 39, 1299 (1977).

DOI: 10.1016/0022-1902(77)80285-6[14] a, b, c, d] D. B. Syme, E. Wood, I. M. Blair, S. Kew and M. Perry, P. Cooper, Yield curves for cyclotron production of I-123, I-125 and I-121 by 127I(p, xn)Xe →(beta decay)→I reactions', Journal of Applied Radiation and Isotopes, 29(1), 29 (1978).

DOI: 10.1016/0020-708x(78)90154-0[15] a, b] H. Lundqvist, P. Malborg, B. Langstrom and S. NaChiengmai, Simple production of Br-77 and I-123 and their use in the labeling of [77Br]BrUdR and [123I]IUdR, Journal of Applied Radiation and Isotopes, 30, 39 (1979).

DOI: 10.1016/0020-708x(79)90095-4[16] a, b] K. Sakamoto, M. Dohniwa and K. Okada, Excitation functions for (p, xn) and (p, pxn) reactions on natural 79+81Br, 85+87Rb, 127I and 133Cs up to Ep=52MeV, Journal of Applied Radiation and Isotopes, 36(6), 481 (1985).

DOI: 10.1016/0020-708x(85)90213-3[17] a, b] M. C. Lagunas-Solar, O.F. Carvacho, Bo. LiLiu and Y. Jin, Cyclotron production of high-purity I-123. A revision of exaction functions, thin-target and cumulative yields for I-127(p, xn) reactions, Journal of Applied Radiation and Isotopes, 37, 823 (1986).

DOI: 10.1016/0883-2889(86)90278-9[18] a, b] C. Deptula, V. A. Kalkin, Kim Sen Han, O. Knotek, V. A. Konov, P. Mikecz, L. M. Popinenkova, E. Rurarz and N. G. Zaitseva, Excitation functions and yields for medically generator Sr-82, Rb-82, Xe-123, I-123 and Bi-201, Pb-201, Tl-201 obtained with 100MeV Protons, Journal of Nukleonika, 35, 3 (1990).

[19] R. Weinreich, O. Schult and G. Stoecklin , Production of I-123 Via the I-127(d, 6n)Xe-123 (BETA+, EC) I-123 process, Journal of Applied Radiation and Isotopes, 25, 535 (1974).

[20] P.J. Husson, Y. Legoux and C. F. Liang, Etude Tude Des Tuxa De formation ansynchrocyclotron D`orsa y Des isotopes a via courte D`iode et DE Xenon a usage medical, Institute department Physics. Nucleaire Orsay Progress Report No. 78, 27, 1 (1978).

[21] (IAEA) International Atomic Energy Agency, Nuclear data for the production of therapeutic radionuclides, Technical report (IAEA-TECDOC-1211), Vienna, 282(2010).